Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 2/20 | 0.40 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | SCN1A | P35498 | 1/20 | 0.39 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.39 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | CTSV | O60911 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29862546 | 1.00 | LMNA (0.40) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL28641542 | 0.81 | MAPT (0.48) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL27279895 | 0.77 | TLR8 (0.45) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL5252565 | 0.76 | PSMB5 (0.40) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL8728861 | 0.76 | LMNA (0.42) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL8728863 | 0.76 | LMNA (0.42) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL28783566 | 0.76 | PLAU (0.41) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL7308613 | 0.76 | MAPT (0.44) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL3272457 | 0.75 | TDP1 (0.44) | LMNAALDH1A1SMN1; SMN2BCHEABCB11 | |
| SCHEMBL25991550 | 0.74 | CA1 (0.47) | LMNAALDH1A1SMN1; SMN2MAPTDHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | SICPA HOLDING SA (CH) | 2025-12-30 | — | — | US | disclosed |
| EP-4069806-B1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2025-04-16 | — | — | EP | disclosed |
| US-20240327736-A1 | METHOD OF MARKING A PETROLEUM HYDROCARBON | SICPA HOLDING SA (CH) | 2024-10-03 | — | — | US | disclosed |
| EP-4069807-B1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-10-04 | — | — | EP | disclosed |
| US-20230103579-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2023-04-06 | — | — | US | disclosed |
| WO-2021110525-A1 | METHOD FOR DETERMINING AUTHENTICITY AND ADULTERATION OF MARKED PETROLEUM HYDROCARBONS | SICPA HOLDING SA (CH) | 2021-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12510529-B2 | Method for determining authenticity and adulteration of marked petroleum hydrocarbons | CYP4A11, CYP11B1, CYP11A1 | LMNA 10/4885ALDH1A1 444/4885SMN1; SMN2 3658/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.